Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia

Pediatric Research

Volumn 62, Issue 5, 2007, Pages 542-546

  Weng, Meiqian ^a   Walker, W Allan ^a,c   Sanderson, Ian R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; INTERLEUKIN 8; LIPOPROTEIN; ANTIINFLAMMATORY AGENT; BUTYRIC ACID DERIVATIVE; GASTROINTESTINAL AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NUCLEAR PROTEIN; PAM(3)CSK(4) PEPTIDE; PEPTIDE; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENTERITIS; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL STRAIN CACO 2; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; INTESTINE; INTESTINE MUCOSA; METABOLISM; ORGAN CULTURE TECHNIQUE; PHOSPHORYLATION; PRENATAL DEVELOPMENT; TIME;

ANTI-INFLAMMATORY AGENTS; BUTYRATES; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL AGENTS; HUMANS; I-KAPPA B PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; INTESTINAL MUCOSA; INTESTINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; ORGAN CULTURE TECHNIQUES; PEPTIDES; PHOSPHORYLATION; TIME FACTORS; TRANSFECTION;

EID: 38849094736     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318155a422     Document Type: Article

References (22)

1. Dotan I, Mayer L 2002 Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 18:421-427
2. Fusunyan RD, Quinn JJ, Fujimoto M, MacDermott RP, Sanderson IR 1999 Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol Med 5:631-640
3. Fusunyan RD, Quinn JJ, Ohno Y, Macdermott RP, Sanderson IR 1998 Butyrate enhances interleukin(IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 43:84-90
4. Huang N, Katz JP, Martin DR, Wu GD 1997 Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 9:27-36
5. Andoh A, Fujiyama Y, Hata K, Araki Y, Takaya H, Shimada M, Bamba T 1999 Counter-regulatory effect of sodium butyrate on tumor necrosis factor-alpha (TNF-α)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol 118:23-29
6. Wu GD, Huang N, Wen X, Keilbaugh SA, Yang H 1999 High-level expression of IkB-β in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role. J Leukoc Biol 66:1049-1056
7. Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP 1998 Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood 92:2924-2933
8. Kogut MH, Iqbal M, He H, Philbin V, Kaiser P, Smith A 2005 Expression and function of Toll-like receptors in chicken heterophils. Dev Comp Immunol 29:791-807
9. Elewaut D, Didonato JA, Kim JM, Truong F, Eckmann L, Kagnoff MF 1999 NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J Immunol 163:1457-1466
10. Vidali G, Boffa LC, Bradbury EM, Allfrey VG 1978 Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci U S A 75:2239-2243
11. Gon Y, Asai Y, Hashimoto S, Mizumura K, Jibiki I, Machino T, Ra C, Horie T 2004 A20 inhibits Toll-like receptor 2- and 4-mediated interleukin 8 synthesis in airway epithelial cells. Am J Respir Cell Mol Biol 31:330-336
12. O'Reilly SM, Moynagh PN 2003 Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. Biochem Biophys Res Commun 303:586-593
13. Furuta GT, Dzus AL, Taylor CT, Colgan SP 2000 Parallel induction of epithelial surface-associated chemokine and proteoglycan by cellular hypoxia: implications for neutrophil activation. J Leukoc Biol 68:251-259
14. Kagnoff MF, Eckmann L 1997 Epithelial cells as sensors for microbial infection. J Clin Invest 100:6-10
15. Ohtsuka Y, Lee J, Stamm DS, Sanderson IR 2001 MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 49:526-533
16. Breuer RI, Soergel KH, Lashner BA, Christ ML, Hanauer SB, Vanagunas A, Harig JM, Keshavarzian A, Robinson M, Sellin JH, Weinberg D, Vidican DE, Flemal KL, Rademaker AW 1997 Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 40:485-491
17. Malago JJ, Koninkx JF, Tooten PC, van Liere EA, van Dijk JE 2005 Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. Clin Exp Immunol 141:62-71
18. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X 2003 SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 4:920-927
19. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL 2002 Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J Biol Chem 277:41701-41705
20. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, Liew Fy 2005 Toll like receptor 2 agonist ameliorates established allergic airways inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174:7558-7563
21. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H 2006 TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance. Biochem Biophys Res Commun 339:1048-1055
22. Fusunyan RD, Quinn JJ, Ohno Y, Macdermott RP, Sanderson IR 1998 Butyrate enhances interleukin(IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 43:84-90